Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

CorMedix- Inc. (CRMD)

0.2751 0.017 (6.63%)

07-19 15:28

Open:

0.264

Pre. Close:

0.258

High:

0.276

Low:

0.26

Volume:

396,055

Market Cap:

23M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.27 - 0.272

0.272 - 0.273

Low:

0.247 - 0.248

0.248 - 0.25

Close:

0.258 - 0.26

0.26 - 0.262

Technical analysis  (as of: 2018-07-19 2:20:22 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.39     One year: 0.45

Support:

Support1: 0.26    Support2: 0.21

Resistance:

Resistance1: 0.33    Resistance2: 0.39

Pivot:

0.26

Moving Averages:

MA(5): 0.26     MA(20): 0.25

MA(100): 0.24     MA(250): 0.40

MACD:

MACD(12,26): 0.01     Signal(12,26,9):

%K %D:

%K(14,3): 68.75     %D(3): 65.97

RSI:

RSI(14): 55.34

52-Week:

High: 0.78  Low: 0.17  Change(%): -32.9

Average Vol(K):

3-Month: 142390  10-Days 109135

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CRMD has closed below upper band by 23.7%. Bollinger Bands are 46.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CRMD's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-16T05:51:44-04:00
CorMedix misses by $0.04, misses on revenue

2018-05-15T20:26:03-04:00
CorMedix's (CRMD) CEO Khoso Baluch on Q1 2018 Results - Earnings Call Transcript

2018-03-19T20:37:05-04:00
CorMedix's (CRMD) CEO Khoso Baluch on Q4 2017 Results - Earnings Call Transcript

2018-02-02T14:05:33-05:00
CorMedix Drug Candidate Lauded By FDA, Approved In The EU, Could Treat Deadly Pathogen Feared By CDC

2017-12-17T16:15:23-05:00
Your Daily Pharma Scoop: Aclaris Gets Approval, Egalet Surges, Alnylam Gains As FDA Lifts Clinical Hold

2017-11-11T13:48:05-05:00
CorMedix's (CRMD) CEO Khoso Baluch on Q3 2017 Results - Earnings Call Transcript

2017-11-10T07:41:25-05:00
CorMedix misses by $0.04, beats on revenue

2017-09-25T09:11:39-04:00
Premarket analyst action - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

81.90

Shares Float (M)

77.88

% Held by Insiders

6.00

% Held by Institutions

15.30

Shares Short (K)

6806

Shares Short Prior Month (K)

Stock Financials

EPS

-0.430

EPS Est. Current Year

-0.530

EPS Est. Next Year

-0.280

EPS Est. Next Quarter

-0.130

Forward EPS

-0.341

Book Value (p.s.)

25.830

PEG Ratio

Profit Margin

Operating Margin

-11340.71

Return on Assets (ttm)

-290.1

Return on Equity (ttm)

-599.1

Qtrly Rev. Growth

-41.3

Gross Profit (p.s.)

0.001

Sales Per Share

EBITDA (p.s.)

-0.184

Qtrly Earnings Growth

Operating Cash Flow (M)

-28.88

Levered Free Cash Flow (M)

-16.02

atoplab.com

Valuation

P/E

-0.64

P/E Growth Ratio

0.06

P/BV

0.01

P/S

P/CF

-0.78

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.